Biomedical Research and Therapy Logo

Biomedical Research and Therapy

Oral Abstracts Open Access Logo

ID:2037 Molecular mechanisms underlying resistance to MEK1/2 inhibitor in BRAF-mutated colorectal cancer

Hong-Quan Duong 1, *

  1. Interdisciplinary Cluster for Applied Genoproteomics (GIGA)
Correspondence to: Hong-Quan Duong, Interdisciplinary Cluster for Applied Genoproteomics (GIGA). Email: [email protected].
Volume & Issue: Vol. 4 No. S (2017): Abstract Proceeding: International conference INNOVATIONS IN CANCER RESEARCH AND REGENERATIVE MEDICINE 2017 | Page No.: S68 | DOI: 10.15419/bmrat.v4iS.276
Published: 2017-09-05

Online metrics

Statistics from the website

  • Abstract Views: 5312
  • Galley Views: 2157

Statistics from Dimensions

Statistics from PlumX
Copyright © 2017 by the author(s).

Copyright The Author(s) 2024. This article is published with open access by BioMedPress. This article is distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0) which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. 

Abstract

Keywords: Cancer, Colorectal cancer, Resistance, MEK1/2 inhibitor, BRAF

Comments